Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Sarcoma and TERT[original query] |
---|
TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors. Journal of neuro-oncology 2014 Nov 120 (2): 267-72. Dubbink Hendrikus J, Bakels Hannah, Post Edward, Zwarthoff Ellen C, Verdijk Robert |
TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients. Molecular and clinical oncology 2016 Jan 4 (1): 61-64. Saito Tsuyoshi, Akaike Keisuke, Kurisaki-Arakawa Aiko, Toda-Ishii Midori, Mukaihara Kenta, Suehara Yoshiyuki, Takagi Tatsuya, Kaneko Kazuo, Yao Takas |
Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia. Journal of translational medicine 2018 Mar 16 (1): 77. Starita Noemy, Buonaguro Luigi, Buonaguro Franco M, Tornesello Maria Li |
Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid Liposarcomas. International journal of molecular sciences 2018 Feb 19 (2): . Ferreira Monica S Ventura, Crysandt Martina, Braunschweig Till, Jost Edgar, Voss Barbara, Bouillon Anne-Sophie, Knuechel Ruth, Brümmendorf Tim H, Beier Fabi |
TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases. Oncology letters 2018 Mar 15 (3): 2763-2770. Insilla Andrea Cacciato, Proietti Agnese, Borrelli Nicla, Macerola Elisabetta, Niccoli Cristina, Vitti Paolo, Miccoli Paolo, Basolo Fulv |
Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations. Human pathology 2019 Mar 85 1-9. Palsgrove Doreen N, Taheri Diana, Springer Simeon U, Cowan Morgan, Guner Gunes, Mendoza Rodriguez Maria A, Rodriguez Pena Maria Del Carmen, Wang Yuxuan, Kinde Isaac, Ricardo Bernardo F P, Cunha Isabela, Fujita Kazutoshi, Ertoy Dilek, Kinzler Kenneth W, Bivalacqua Trinity J, Papadopoulos Nickolas, Vogelstein Bert, Netto George |
Genomic landscape of gliosarcoma: distinguishing features and targetable alterations. Scientific reports 2021 Sep 11 (1): 18009. Zaki Mark M, Mashouf Leila A, Woodward Eleanor, Langat Pinky, Gupta Saksham, Dunn Ian F, Wen Patrick Y, Nahed Brian V, Bi Wenya Lin |
Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 6 35 (11): 1644-1655. Dermawan Josephine K, Hwang Sinchun, Wexler Leonard, Tap William D, Singer Samuel, Vanderbilt Chad M, Antonescu Cristina |
TINF2 is a major susceptibility gene in Danish patients with multiple primary melanoma. HGG advances 2023 8 4 (4): 100225. Marlene Richter Jensen, Anne Marie Jelsig, Anne-Marie Gerdes, Lisbet Rosenkrantz Hölmich, Kati Hannele Kainu, Henrik Frank Lorentzen, Mary Højgaard Hansen, Mads Bak, Peter A Johansson, Nicholas K Hayward, Thomas Van Overeem Hansen, Karin A W Wa |
BRAF mutations and concurrent alterations in patients with soft tissue sarcoma. Genes, chromosomes & cancer 2023 6 . Hiroshi Kobayashi, Liuzhe Zhang, Koichi Okajima, Yuki Ishibashi, Toshihide Hirai, Yusuke Tsuda, Masachika Ikegami, Hidenori Kage, Aya Shinozaki-Ushiku, Katsutoshi Oda, Sakae Tana |
TERT Mutations in Non-Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Implications. Clinical Medicine Insights. Oncology 2023 6 17 11795549221140781. Liu Yang, Meng Wang, Na Li, Lu-Da Yan, Wen Zhou, Zhi-Qiong Yu, Xiao-Chun Peng, Jun Cai, Yong-Hua Ya |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: